Proprietary Candidate Portfolio
Not Specified (Plasma-derived therapies)
PreclinicalActive
Key Facts
About PreviPharma
PreviPharma Consulting GmbH, founded in 2018 and headquartered in Hamburg, Germany, is a specialized service provider and research partner to the global plasma fractionation industry. The company offers comprehensive R&D support across the entire value chain, including medical strategy, process development, preclinical and clinical studies, analytical methods, and contract manufacturing. With a team of approximately 70, proprietary preclinical assets, and facilities in Mannheim and Hyderabad, it positions itself as an accelerator for plasma protein innovations.
View full company profile